Company to Participate in Upcoming Conferences WASHINGTON, July 11, 2024 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company that specializes in better health outcomes for people with complex conditions through proven solutions that make health care simpler and more affordable, today announced it will release its second quarter 2024 financial results on Thursday, August 8, 2024, after market close, with a conference call to follow at 5 p.m. ET. Evolent Health Logo (PRNewsfoto/Evolent Health) Shareholders and interested participants may listen to a live broadcast of the conference found on Evolent's investor relations website, https://ir.evolent.com. Analysts interested in asking questions during the live call should dial 855.940.9467, or 412.317.6034 for international callers, and reference the "Evolent call" 15 minutes prior to the call. An audio playback of the conference call will be available on Evolent's investor relations website for 90 days after the call. Upcoming Investor Events Additionally, The Company announced that its executive management team will participate in upcoming investor conferences. A live audio-only webcast and replay for these events will be available, if applicable, on the investor relations section of Evolent's website, unless otherwise noted below. Canaccord Genuity 44th Annual Growth Conference at the InterContinental Boston Hotel, Boston, Massachusetts, on August 13, 2024. A live broadcast of management's presentation will take place at 8:30 a.m. ET. 2024 Bernstein Disruptor Conference at the Alliance Bernstein Offices Midtown in New York, New York, on September 24, 2024. A live webcast, if available, will be posted to Evolent's investor relations website. About Evolent Evolent specializes in better health outcomes for people with complex conditions through proven solutions that make health care simpler and more affordable. Evolent serves a national base of leading payers and providers and is consistently recognized as a top place to work in health care nationally. Learn more about how Evolent is changing the way health care is delivered by visiting https://ir.evolent.com. Contacts: Seth R. Frank Vice President, Investor Relations Evolent [email protected] 571-895-3919 (W) Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/evolent-to-release-second-quarter-2024-financial-results-on-thursday-august-8-2024-302194326.html SOURCE Evolent Health, Inc.
Evolent To Release Second Quarter 2024 Financial Results on Thursday, August 8, 2024
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...